4Filing Date: Jan 28, 2026
Msci 4: Wiechmann Andrew C. bought 5,639 shares of Option to purcha… (Jan 28, 2026)
Statement of Changes in Beneficial Ownership
View SEC Filing
ACC: 0001769683-26-000002
Total Value$0
Trades1
Insiders1
Transaction Details
Wiechmann Andrew C.
Chief Financial Officer·Direct
Grant · Acquire
Option to purchase common stockDerivative
Shares+5.64K
Price$0.00
Total Value$0
Shares Owned After5.64K
Transaction DateJan 26, 2026
ExpiresFeb 2, 2033
Footnotes ▸
Represents the number of performance stock options ("PSOs") to purchase common stock earned by the reporting person following the certification by the Compensation, Talent and Culture Committee on January 26, 2026 of the achievement of the performance condition applicable to the PSOs. The PSOs were granted on February 2, 2023 and vest on the third anniversary of the grant date, subject to continuous service through such date and satisfaction of the performance condition for the performance period from January 1, 2023 and ending on December 31, 2025. The performance condition for the PSOs was met with respect to 5,639 shares of common stock, and the PSOs are scheduled to vest on February 2, 2026.
Post-Transaction Holdings
Wiechmann Andrew C. · Chief Financial Officer
| Security | Shares | Change |
|---|---|---|
| Option to purchase common stock | 5.64K | +5.64K |
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership ===
Document Type: 4
Period of Report: 2026-01-26
10b5-1 Pre-arranged Plan: No
--- Issuer ---
Name: MSCI Inc. (MSCI)
CIK: 0001408198
--- Reporting Owner ---
Name: Wiechmann Andrew C.
CIK: 0001769683
Role: Officer (Chief Financial Officer)
--- Derivative Transactions ---
[Transaction #1]
Security: Option to purchase common stock
Date: 2026-01-26 | Code: A (Grant or award)
Shares: +5,639 | Price: $0.00
Exercisable: N/A | Expires: 2033-02-02
Shares Owned After: 5,639 | Ownership: D (Direct)
Footnotes:
[F1] Represents the number of performance stock options ("PSOs") to purchase common stock earned by the reporting person following the certification by the Compensation, Talent and Culture Committee on January 26, 2026 of the achievement of the performance condition applicable to the PSOs. The PSOs were granted on February 2, 2023 and vest on the third anniversary of the grant date, subject to continuous service through such date and satisfaction of the performance condition for the performance period from January 1, 2023 and ending on December 31, 2025. The performance condition for the PSOs was met with respect to 5,639 shares of common stock, and the PSOs are scheduled to vest on February 2, 2026.
--- Footnotes (Complete Index) ---
F1: Represents the number of performance stock options ("PSOs") to purchase common stock earned by the reporting person following the certification by the Compensation, Talent and Culture Committee on January 26, 2026 of the achievement of the performance condition applicable to the PSOs. The PSOs were granted on February 2, 2023 and vest on the third anniversary of the grant date, subject to continuous service through such date and satisfaction of the performance condition for the performance period from January 1, 2023 and ending on December 31, 2025. The performance condition for the PSOs was met with respect to 5,639 shares of common stock, and the PSOs are scheduled to vest on February 2, 2026.
--- Signature ---
/s/ /s/ Cecilia Aza, attorney-in-fact (2026-01-28)